£380.00

Description

Connective Tissue Disease Blood Panel

Connective Tissue Disease Blood Panel

£380.00

🔍 Service Overview

Connective Tissue Diseases (CTDs) are chronic, systemic autoimmune disorders that can affect multiple organs and systems, including the joints, muscles, skin, blood vessels, lungs, kidneys, and heart. These diseases often share overlapping symptoms, making accurate and early diagnosis both complex and critical.

This comprehensive blood panel is designed to screen, detect, and support differential diagnosis of a wide range of autoimmune and inflammatory connective tissue disorders. It’s also valuable for disease monitoring, especially in individuals with evolving or unclear autoimmune symptoms.

🧪 What's Included in This Panel?

Haematological and Inflammatory Markers

These offer insight into immune system activity and systemic inflammation:

Full Blood Count (FBC): Detects anaemia, low platelets (often seen in lupus), and signs of chronic inflammation or immune suppression.

Erythrocyte Sedimentation Rate (ESR): Measures how quickly red blood cells settle at the bottom of a test tube — a non-specific marker of chronic inflammation.

C-Reactive Protein (CRP): A sensitive marker of acute inflammation and tissue injury; elevated in many autoimmune flares.

Uric Acid: Assesses for hyperuricaemia, which may indicate gout, overlap syndromes, or renal impairment.

Autoimmune Core Antibodies

These target components of the body's own cells and are hallmark indicators of autoimmune processes:

ANA (Antinuclear Antibody): The first-line test for autoimmune diseases like lupus, systemic sclerosis, and Sjögren’s. A positive ANA warrants further testing.

Anti-dsDNA: Highly specific for Systemic Lupus Erythematosus (SLE). Associated with renal involvement and lupus nephritis.

Rheumatoid Arthritis Markers

Rheumatoid Factor (RF): An antibody seen in 70–80% of rheumatoid arthritis cases, though also found in other autoimmune conditions.

Anti-CCP (Cyclic Citrullinated Peptide): Highly specific for rheumatoid arthritis and may appear before symptoms begin. Helps confirm diagnosis in seronegative cases.

Genetic Risk Marker – HLA-B27

A genetic marker strongly linked to seronegative spondyloarthropathies, such as:

Ankylosing Spondylitis

Psoriatic Arthritis

Reactive Arthritis

Inflammatory Bowel Disease-related arthritis

Presence of HLA-B27, particularly in patients with chronic back pain, morning stiffness, or eye inflammation, increases suspicion of these conditions.

🧬 Extractable Nuclear Antigen (ENA) Panel

Detects specific autoantibodies that help distinguish between different connective tissue disorders:

Antibody

Associated Disease

Clinical Relevance

Anti-Sm

Systemic Lupus Erythematosus

Highly specific for SLE

Anti-nRNP

Mixed Connective Tissue Disease (MCTD)

Present in overlap syndromes

Anti-Ro (SSA)

Sjögren’s, SLE, neonatal lupus

May cause heart block in infants of affected mothers

Anti-La (SSB)

Sjögren’s syndrome

Often appears with Anti-Ro

Anti-Scl-70 (Topoisomerase I)

Systemic Sclerosis (Diffuse form)

Associated with lung fibrosis and skin thickening

Anti-CENP (Centromere Antibody)

Limited Cutaneous Systemic Sclerosis (CREST syndrome)

Associated with milder skin involvement and pulmonary hypertension

Anti-Jo-1

Polymyositis, Dermatomyositis

Related to muscle inflammation and interstitial lung disease

These markers are critical for subclassifying diseases and predicting organ involvement.

📋 What You’ll Receive

A comprehensive, clinician-reviewed report explaining your results clearly and accurately

A traffic light flagging system (green, amber, red) to guide urgency

Personalised next-step recommendations,

Suggested GP or specialist referrals

Guidance on further diagnostic imaging, if needed

Monitoring or management options if results are borderline

👩⚕️ Who Should Consider This Test?

This panel is suitable for individuals who:

Have persistent joint or muscle pain

Experience unexplained fatigue, fevers, rashes, or weight changes

Have Raynaud’s phenomenon (cold-triggered colour changes in fingers/toes)

Have a family history of autoimmune disease

Experience dry eyes, dry mouth, or skin thickening

Show abnormal results on previous blood work (e.g. ANA positive)

Frequently Asked Questions

What are connective tissue diseases?

They are a group of autoimmune conditions in which the immune system attacks the body's own connective tissues, such as collagen and elastin. These tissues provide structure and support to organs, joints, and skin.

Is this a diagnostic or screening test?

This is a diagnostic aid and a screening tool. It provides strong clinical evidence to support a diagnosis, but it must be combined with a physical exam, symptom history, and specialist assessment.

Will this test diagnose lupus, scleroderma, or arthritis?

It will detect antibody patterns and inflammation levels associated with those diseases. A positive result suggests autoimmune activity and supports diagnosis, but further evaluation is required to confirm.

How long will my results take?

Results are typically available within 3–5 working days, with a secure login portal for immediate access and a downloadable report for your GP or specialist.

Do I need to fast before the test?

No fasting is required for this test.

What if my results are positive?

Yes. This panel works well alongside:

  • Thyroid antibody testing
  • Vitamin D and B12 panels
  • Full autoimmune panels
  • Inflammatory bowel disease screens

We can create a bespoke health assessment tailored to your needs.

Can this be part of a broader health MOT?

Yes. This panel works well alongside:

  • Thyroid antibody testing
  • Vitamin D and B12 panels
  • Full autoimmune panels
  • Inflammatory bowel disease screens

We can create a bespoke health assessment tailored to your needs